Platelet adenosine diphosphate receptor antagonists: ticlopidine to ticagrelor—a long continuing journey

Balsano, 1990, Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio Della Ticlopidina nell'Angina Instabile Group, Circulation, 82, 17, 10.1161/01.CIR.82.1.17 Goods, 1996, Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting, Am J Cardiol, 78, 1042, 10.1016/S0002-9149(96)00532-2 Bertrand, 2000, Circulation, 102, 624, 10.1161/01.CIR.102.6.624 CAPRIE Steering Committee, 1996, A randomised blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3 Yusuf, 2001, Clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med, 345, 494, 10.1056/NEJMoa010746 Mehta, 2001, Clopidogrel in unstable angina to prevent recurrent events trial (CURE) investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, Lancet, 358, 527, 10.1016/S0140-6736(01)05701-4 Sabatine, 2005, N Engl J Med, 352, 1179, 10.1056/NEJMoa050522 Chen, 2005, COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial, Lancet, 366, 1607, 10.1016/S0140-6736(05)67660-X Dangas, 2009, Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial, J Am Coll Cardiol, 54, 1438, 10.1016/j.jacc.2009.06.021 The CURRENT-OASIS 7 Investigators, 2010, Dose comparisons of clopidogrel andaspirin in acute coronary syndromes, N Engl J Med, 363, 930, 10.1056/NEJMoa0909475 Gurbel, 2003, Clopidogrel for coronary stenting. Response variability, drug resistance, and the effect of pre-treatment platelet reactivity, Circulation, 107, 2908, 10.1161/01.CIR.0000072771.11429.83 Mega, 2009, Cytochrome P-450 polymorphisms and response to clopidogrel, N Engl J Med, 360, 354, 10.1056/NEJMoa0809171 Frere, 2008, Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome, Am J Cardiol, 101, 1088, 10.1016/j.amjcard.2007.11.065 Angiolillo, 2007, Variability in individual responsiveness to clopidogrel: clinical implications, management and future perspectives, J Am Coll Cardiol, 49, 1505, 10.1016/j.jacc.2006.11.044 Wiviott, 2004, Clopidogrel resistance: a new chapter in a fast-moving story, Circulation, 109, 3064, 10.1161/01.CIR.0000134701.40946.30 Wallentin, 2008, Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease, Eur Heart J, 29, 21, 10.1093/eurheartj/ehm545 Wiviott, 2007, TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 357, 2001, 10.1056/NEJMoa0706482 Bhatt, 2009, Prasugrel in Clinical Practice, N Engl J Med, 361, 940, 10.1056/NEJMp0806848 Curfman, 2007, Drug-eluting coronary stents-promise and uncertainty, N Engl J Med, 356, 1059, 10.1056/NEJMe068306 Bavry, 2008, Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis, Lancet, 371, 2134, 10.1016/S0140-6736(08)60922-8 Storey, 2007, Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes, J Am Coll Cardiol, 50, 1852, 10.1016/j.jacc.2007.07.058 Husted, 2006, Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin, Eur Heart J, 27, 1038, 10.1093/eurheartj/ehi754 Wallentin, 2009, Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 361, 1045, 10.1056/NEJMoa0904327 Cannon, 2010, Ticagrelor compared with clopidogrel in acute coronary syndromes patients with a planned invasive strategy (PLATO): a randomized double-blind study, Lancet, 375, 283, 10.1016/S0140-6736(09)62191-7 Schömig, 2009, Ticagrelor-is there need for a new player in the antiplatelet-therapy field?, N Engl J Med, 361 Ticagrelor versus clopidogrel in patients with acute coronary syndrome intended for non invasive management: sub study from prospective randomized platelet inhibition and outcomes (PLATO) trial. Held, 2011, Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing coronary artery bypass surgery: results from PLATO trial, L Am Coll Cardiol, 57, 672, 10.1016/j.jacc.2010.10.029 Levine, 2011, 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions, Circulation, 124, e574 Hamm, 2011, Eur Heart J